Using multiple approaches, we show that RPG-01-132's sub-micromolar antiviral activity is due to CRL4<sup>CRBN</sup>-dependent degradation of capsid and that this mechanism disrupts capsid-related pathways required for productive infection, including infectious virus output and capsid-mediated antagonism of the interferon response. Here, CRBN is linked to infection.